Related references
Note: Only part of the references are listed.A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary
V. Papp et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Epidemiology of pediatric multiple sclerosis, neuromyelitis optica, and optic neuritis in Taiwan
Wei-Sheng Lin et al.
JOURNAL OF NEUROLOGY (2020)
Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric Patients
Amy Kunchok et al.
JAMA NEUROLOGY (2020)
International multicenter examination of MOG antibody assays
Markus Reindl et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Prevalence and Incidence of Neuromyelitis Optica Spectrum Disorder in Korea: Population Based Study
Hye Lim Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Neuromyelitis optica spectrum disorders: still evolving and broadening
Kazuo Fujihara
CURRENT OPINION IN NEUROLOGY (2019)
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
Jacqueline Palace et al.
BRAIN (2019)
Epidemiology of NMOSD in Sweden from 1987 to 2013
Dagur Ingi Jonsson et al.
NEUROLOGY (2019)
Epidemiology of neuromyelitis optica spectrum disorder in Denmark (1998-2008,2007-2014)
Nasrin Asgari et al.
BRAIN AND BEHAVIOR (2019)
Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka
Bimsara Senanayake et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008-2018: A nationwide, population-based cohort study
Magnus S. Boesen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Sex differences in autoimmune disorders of the central nervous system
Stefan M. Gold et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Cranial nerve involvement in patients with MOG antibody-associated disease
Alvaro Cobo-Calvo et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
Maria Sepulveda et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
Maria Sepulveda et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Nationwide epidemiological study of neuromyelitis optica in Japan
Katsuichi Miyamoto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults The MOGADOR study
Alvaro Cobo-Calvo et al.
NEUROLOGY (2018)
Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence
Jyh Yung Hor et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Lower frequency of antibodies to MOG in Brazilian patients with demyelinating diseases: An ethnicity influence?
Regina Maria Papais-Alvarenga et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta
Sara Salama et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder
Ram Narayan et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark
Viktoria Papp et al.
NEUROLOGY (2018)
Racial differences in neuromyelitis optica spectrum disorder
Su-Hyun Kim et al.
NEUROLOGY (2018)
Neurodegeneration in multiple sclerosis and neuromyelitis optica
Izumi Kawachi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients
Shahd H. M. Hamid et al.
JOURNAL OF NEUROLOGY (2017)
Incidence and prevalence of NMOSD in Australia and New Zealand
Wajih Bukhari et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan
Hideki Houzen et al.
NEUROLOGY (2017)
Neuromyelitis optica spectrum disorders in Iran
Sharareh Eskandarieh et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Maciej Jurynczyk et al.
BRAIN (2017)
MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
Ryo Ogawa et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients
Sasitorn Siritho et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients
Sasitorn Siritho et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Epidemiology of Aquaporin-4 Autoimmunity and Neuromyelitis Optica Spectrum
Eoin P. Flanagan et al.
ANNALS OF NEUROLOGY (2016)
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Patrick Waters et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Neuromyelitis optica spectrum disorders in Algeria: A preliminary study in the region of Tizi Ouzou
Smail Daoudi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
DoesMOGIg-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
Scott S. Zamvil et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
An epidemiological study of neuromyelitis optica in Isfahan
Masoud Etemadifar et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India
Lekha Pandit et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Douglas Kazutoshi Sato et al.
NEUROLOGY (2014)
A Genetic Atlas of Human Admixture History
Garrett Hellenthal et al.
SCIENCE (2014)
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
Joanna Kitley et al.
JAMA NEUROLOGY (2014)
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
Elaine Kingwell et al.
BMC NEUROLOGY (2013)
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom
Anu Jacob et al.
JOURNAL OF NEUROLOGY (2013)
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status
Satoshi Yoshimura et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Incidence and Prevalence of Multiple Sclerosis in the Americas: A Systematic Review
Charity Evans et al.
NEUROEPIDEMIOLOGY (2013)
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People
Fahmy Aboul-Enein et al.
PLOS ONE (2013)
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
Joanna Kitley et al.
BRAIN (2012)
The prevalence of neuromyelitis optica in South East Wales
M. Cossburn et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan
Hideki Houzen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Joanna Kitley et al.
NEUROLOGY (2012)
HLA-DPB1*0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in Southern Han Chinese
Honghao Wang et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
A population-based study of neuromyelitis optica in Caucasians
N. Asgari et al.
NEUROLOGY (2011)
An epidemiological study of neuromyelitis optica in Cuba
Jose A. Cabrera-Gomez et al.
JOURNAL OF NEUROLOGY (2009)
Descriptive epidemiology of neuromyelitis optica in the Caribbean basin
P. Cabre et al.
REVUE NEUROLOGIQUE (2009)
Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders
T. Matsushita et al.
TISSUE ANTIGENS (2009)
Characteristics of Devic's disease (neuromyelitis optica) in Mexico
Jose Flores Rivera et al.
JOURNAL OF NEUROLOGY (2008)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
MS and neuromyelitis optics in Martinique (French West Indies)
P Cabre et al.
NEUROLOGY (2001)
Aboriginals with multiple sclerosis - HLA types and predominance of neuromyelitis optica
SM Mirsattari et al.
NEUROLOGY (2001)
Share Paper
